In line with the animal study, the expression of HIF-1α was significant higher in human AD samples compared with the control group as evidenced by western blot analysis and immunohistochemical staining (Figure S4A-D), which implies that HIF-1α could be an important player in the occurrence and development of AD and a potential therapeutic target for AD treatment. This evidence concerns the gene HIF1A and Alzheimer disease.